Clinical study of an autologous adipose extracellular matrix/stromal vascular fraction gel (ECM/SVF-gel) in the promotion of acute and chronic wounds healing.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034624

Enrollment

Unknown

Registered

2020-07-12

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute and chronic wounds

Interventions

experimental group:SVF-gel

control group:Conventional standard therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with wound; 2. Female or male patient 18 to 60 years of age with diagnosis wounds; 3. Subject has adequate (>200cc) abdominal or other subcutaneous adipose tissue accessible by syringe-based lipoharvest; 4. Subject or legal representative informed consent, volunteered to test, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Requirement for the use of systemic corticosteroidscytotoxic agentsimmuno- suppressive agents and other treatments; 2. There are other basic diseases such as cardiovascular and cerebrovascular diseases; 3. Pregnant, pregnant or lactating subjects; 4. Serious systemic or local skin infection; 5. Participating in other clinical trials within 3 months; 6. The patient cannot cooperate with the trial-related content due to various reasons such as mental, cognitive, and language.

Design outcomes

Primary

Measure	Time frame
Wound healing rate;Histological detection;	—

Countries

China

Contacts

Public ContactChenliang Deng

Zunyi Medical College Hospital

cheliadeng@sina.com+86 15085115296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026